Comparison of the outcomes of stereotactic body radiotherapy and surgery in elderly patients with cT1-2N0M0 non-small cell lung cancer

Respiratory Investigation

Volumn 52, Issue 4, 2014, Pages 221-226

  Nakagawa, Tatsuo ^a   Negoro, Yoshiharu ^a   Matsuoka, Tomoaki ^b   Okumura, Norihito ^b   Dodo, Yoshihiro ^b  

^a TENRI HOSPITAL   (Japan)

^b KURASHIKI CENTRAL HOSPITAL   (Japan)

Author keywords

Elderly patients; Lung cancer; Stereotactic body radiotherapy; Surgery

Indexed keywords

AGE; AGED; ARTICLE; CANCER STAGING; CANCER SURVIVAL; CONTROLLED STUDY; FEMALE; FORCED EXPIRATORY VOLUME; HUMAN; INTERMETHOD COMPARISON; LUNG LOBECTOMY; LUNG NON SMALL CELL CANCER; LUNG RESECTION; LUNG SURGERY; MAJOR CLINICAL STUDY; MALE; OVERALL SURVIVAL; RADIATION DOSE; STEREOTACTIC BODY RADIATION THERAPY; SURVIVAL RATE; SURVIVAL TIME; TREATMENT OUTCOME; TUMOR VOLUME; WEDGE RESECTION; CARCINOMA, NON-SMALL-CELL LUNG; COMPARATIVE STUDY; FOLLOW UP; LUNG NEOPLASMS; MULTIVARIATE ANALYSIS; PATHOLOGY; PATHOPHYSIOLOGY; PROCEDURES; RADIOSURGERY; VERY ELDERLY; CANCER PROGNOSIS; CANCER RECURRENCE; ELDERLY CARE; FUNCTIONAL STATUS; LOG RANK TEST; MEDICAL RECORD REVIEW; NON SMALL CELL LUNG CANCER; RADIATION DOSE FRACTIONATION; SURGICAL TECHNIQUE;

AGE FACTORS; AGED; AGED, 80 AND OVER; CARCINOMA, NON-SMALL-CELL LUNG; FEMALE; FOLLOW-UP STUDIES; HUMANS; LUNG NEOPLASMS; MALE; MULTIVARIATE ANALYSIS; NEOPLASM STAGING; PNEUMONECTOMY; RADIOSURGERY; RADIOTHERAPY DOSAGE; SURVIVAL RATE; TREATMENT OUTCOME;

EID: 84903772655     PISSN: 22125345     EISSN: 22125353     Source Type: Journal    
DOI: 10.1016/j.resinv.2014.01.002     Document Type: Article

References (17)

1. Mountain C.F. Revisions in the International System for Staging Lung Cancer. Chest 1997, 111:1710-1717.
2. Naruke T., Goya T., Tsuchiya R., et al. Prognosis and survival in resected lung carcinoma based on the new international staging system. J Thorac Cardiovasc Surg 1988, 96:440-447.
3. Nyman J., Johansson K.A., Hultén U. Stereotactic hypofractionated radiotherapy for stage I non-small cell lung cancer - mature results for medically inoperable patients. Lung Cancer 2006, 51:97-103.
4. Hoyer M., Roed H., Hansen A.T., et al. Prospective study on stereotactic radiotherapy of limited-stage non-small-cell lung cancer. Int J Radiat Oncol Biol Phys 2006, 66(Suppl.):S128-S135.
5. Fakiris A.J., McGarry R.C., Yiannoutsos C.T., et al. Stereotactic body radiation therapy for early-stage non-small-cell lung carcinoma: four-year results of a prospective phase II study. Int J Radiat Oncol Biol Phys 2009, 75:677-682.
6. Ricardi U., Filippi A.R., Guarneri A., et al. Stereotactic body radiation therapy for early stage non-small cell lung cancer: results of a prospective trial. Lung Cancer 2010, 68:72-77.
7. Nagata Y., Takayama K., Matsuo Y., et al. Clinical outcomes of a phase I/II study of 48Gy of stereotactic body radiotherapy in 4 fractions for primary lung cancer using a stereotactic body frame. Int J Radiat Oncol Biol Phys 2005, 63:1427-1431.
8. Baumann P., Nyman J., Lax I., et al. Factors important for efficacy of stereotactic body radiotherapy of medically inoperable stage I lung cancer. A retrospective analysis of patients treated in the Nordic countries. Acta Oncol 2006, 45:787-795.
9. Onishi H., Shirato H., Nagata Y., et al. Hypofractionated stereotactic radiotherapy (HypoFXSRT) for stage I non-small cell lung cancer: updated results of 257 patients in a Japanese multi-institutional study. J Thorac Oncol 2007, 2(7 Suppl. 3):S94-S100.
10. American Joint Committee on Cancer (AJCC), Lung. In: Edge SB, Byrd DR, Compton CC, et al., editors. AJCC cancer staging manual. 7th ed. New York: Springer; 2010. p. 253-70.
11. Nagata Y., Hiraoka M., Shibata T., et al. A phase II trial of stereotactic body radiation therapy for operable T1N0M0 non-small cell lung cancer: Japan Clinical Oncology Group (JCOG0403). Int J Radiat Oncol Biol Phys 2010, 78(Suppl.):S27-S28.
12. Cerfolio R.J., Bryant A.S. Survival and outcomes of pulmonary resection for non-small cell lung cancer in the elderly: a nested case-control study. Ann Thorac Surg 2006, 82:424-429.
13. Chambers A., Routledge T., Pilling J., et al. In elderly patients with lung cancer is resection justified in terms of morbidity, mortality and residual quality of life?. Interact Cardiovasc Thorac Surg 2010, 10:1015-1021.
14. Crabtree T.D., Denlinger C.E., Meyers B.F., et al. Stereotactic body radiation therapy versus surgical resection for stage I non-small cell lung cancer. J Thorac Cardiovasc Surg 2010, 140:377-386.
15. Kirmani B.H., Rintoul R.C., Win T., et al. Stage migration: results of lymph node dissection in the era of modern imaging and invasive staging for lung cancer. Eur J Cardiothorac Surg 2013, 43:104-109.
16. Lee P.C., Port J.L., Korst R.J., et al. Risk factors for occult mediastinal metastases in clinical stage I non-small cell lung cancer. Ann Thorac Surg 2007, 84:177-181.
17. Park H.K., Jeon K., Koh W.J., et al. Occult nodal metastasis in patients with non-small cell lung cancer at clinical stage IA by PET/CT. Respirology 2010, 15:1179-1184.